Generation Bio EPS - Earnings per Share 2020-2023 | GBIO
Generation Bio eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Generation Bio Annual EPS |
| 2023 |
$-1.96 |
| 2022 |
$-2.35 |
| 2021 |
$-2.12 |
| 2020 |
$-2.95 |
| 2019 |
$-12.96 |
| Generation Bio Quarterly EPS |
| 2023-12-31 |
$-0.53 |
| 2023-09-30 |
$-0.43 |
| 2023-06-30 |
$-0.47 |
| 2023-03-31 |
$-0.53 |
| 2022-12-31 |
$-0.55 |
| 2022-09-30 |
$-0.53 |
| 2022-06-30 |
$-0.66 |
| 2022-03-31 |
$-0.61 |
| 2021-12-31 |
$-0.55 |
| 2021-09-30 |
$-0.56 |
| 2021-06-30 |
$-0.55 |
| 2021-03-31 |
$-0.46 |
| 2020-12-31 |
$2.23 |
| 2020-09-30 |
$-0.46 |
| 2020-06-30 |
$-1.50 |
| 2020-03-31 |
$-3.22 |
| 2019-12-31 |
$0.00 |
| 2019-09-30 |
$-3.31 |
| 2019-06-30 |
$-3.30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
